Israel Englander’s Freeline Therapeutics Holdings plc American Depositary Shares FRLN Stock Holding History

Israel Englander’s Portfolio FRLN Stock Details FRLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-370,543	Closed	-$1.57M	–	6709
2023 Q3	$1.57M	Buy	+370,543	New	+$1.47M	﹤0.01%	3796
2023 Q2	–	Sell	-10,814	Closed	-$75K	–	6908
2023 Q1	$75K	Buy	10,814 +9,045	+511%	+$70.2K	﹤0.01%	5511
2022 Q4	$13K	Buy	+1,769	New	+$16.8K	﹤0.01%	6149
2021 Q3	–	Sell	-3,976	Closed	-$486K	–	7397
2021 Q2	$486K	Sell	3,976 -481	-11%	-$74.8K	﹤0.01%	5330
2021 Q1	$822K	Sell	4,457 -347	-7%	-$82.3K	﹤0.01%	4395
2020 Q4	$1.32M	Sell	4,804 -3,491	-42%	-$878K	﹤0.01%	3545
2020 Q3	$1.94K	Buy	+8,295	New	+$2.08M	﹤0.01%	2619

Other funds holding FRLN

Syncona Portfolio St Peter Port, Guernsey $26.6M AUM 10.36% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PCM

PenderFund Capital Management Vancouver, British Columbia, Canada $780M AUM 24.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

HCA

Harbor Capital Advisors Chicago, Illinois $1.47B AUM 42.58% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Israel Englander's FRLN Position: Q4 2023 in Review

Israel Englander sold out of Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) in Q4 2023, closing a stake of 370,543 shares — an estimated $1.57M sold.

Israel Englander first reported a position in FRLN in Q3 2020 and held it in 7 quarters. The position peaked at $1.57M in Q3 2023. 15 funds tracked by Wall St. Rank hold FRLN as of Q4 2023.

Israel Englander reported no remaining Freeline Therapeutics Holdings plc American Depositary Shares position as of Q4 2023 after selling out during the quarter.
Israel Englander sold 370,543 Freeline Therapeutics Holdings plc American Depositary Shares shares in Q4 2023, an estimated $1.57M.
Israel Englander first reported a position in Freeline Therapeutics Holdings plc American Depositary Shares in Q3 2020 and held it in 7 quarters.
Israel Englander's Freeline Therapeutics Holdings plc American Depositary Shares position peaked at $1.57M in Q3 2023.
15 funds tracked by Wall St. Rank held Freeline Therapeutics Holdings plc American Depositary Shares as of Q4 2023.

Based on Millennium Management's 13F filing for Q4 2023, filed 14 Feb 2024.